Hepatitis B virus preCore/Core region variability in pregnant women in the Republic of Guinea

• Published in: Žurnal mikrobiologii, ėpidemiologii i immunobiologii Vol. 101; no. 1; pp. 61 - 71
• Main Authors: Yulia V. Ostankova, Thierno A.L. Balde, Sanaba Boumbaly, Elena N. Serikova, Elena B. Zueva, Diana E. Reingardt, Alexandr N. Schemelev, Vladimir S. Davydenko, Ekaterina V. Anufrieva, Elena V. Esaulenko, Areg A. Totolian
• Format: Journal Article
• Language: English
• Published: Central Research Institute for Epidemiology 13-03-2024
• Subjects: clinically significant mutations; genotypes; hbv variability; hepatitis b virus; laboratory diagnostics; occult hepatitis b; precore/core
• ISSN: 0372-9311; 2686-7613
• DOI: 10.36233/0372-9311-447

Introduction. The vertical route of hepatitis B virus (HBV) transmission is a significant problem in African countries, which is characterized by late diagnosis of the disease and high mortality. The high prevalence of hepatocellular carcinoma (HCC) in Africa may be due to variability in the HBV preCore/Core region, mutations in which contribute to disease progression. Molecular genetic characterization of strains circulating among pregnant women may reflect the overall mutational profile of the pathogen in the population. The objective of this study was to analyze the variability of the HBV preCore/Core region circulating among pregnant women in the Republic of Guinea. Materials and methods. The study material included 480 plasma samples obtained from HBV-positive pregnant women from the Republic of Guinea. For all samples, the nucleotide sequences of the preCore/Core region of the HBV genome were sequenced and analyzed. Results. Amino acid variability in the preCore region was determined in 211 (43.96%), and in the Core region in 473 (98.54%) patients. 12 polymorphic sites of the preCore region were identified in which amino acid substitutions occurred, including 8, 2 and 5 positions identified for genotypes E, A and D, respectively. In the Core region, 67 substitution positions were identified, including 46 in samples of genotype E, 23 in HBV genotype A and 26 in genotype D. It was shown that the distribution of substitutions in the preCore and Core regions in HBV genotypes E, A and D differs significantly with a predominance in mutations among HBV genotype E — p 0.0001. Individual characteristic mutations have been identified for each genotype. The most common clinically significant mutations in the preCore/Core region in the study group were identified, including pc-H5D (27,08%), pc-W28* (35,21%), c-E64D (33,54%), c-L116I/V/G (91,46 %), c-T146N (73,13%). The double mutation A1762T/G1764A in the basal core promoter was shown in 74 samples of HBV genotype E, which accounted for 15.42% of the total group and 16.59% of patients with HBV genotype E. Conclusion. The frequency of clinically significant preCore/Core mutations among pregnant women in the Republic of Guinea was determined. The data obtained reflect their prevalence in the general population and can be used to predict the progression of chronic HBV among the region's population.